Melatonin prevents lipopolysaccharide-induced hyporeactivity in rat

Journal of Pineal Research

Volumn 36, Issue 3, 2004, Pages 146-154

  Di Villa Bianca, Roberta D'Emmanuele ^a   Marzocco, Stefania ^b   Rosanna, Di Paola ^c   Autore, Giuseppina ^b   Pinto, Aldo ^b   Cuzzocrea, Salvatore ^c   Sorrentino, Raffaella ^a  

^a UNIVERSITY OF NAPLES FEDERICO II   (Italy)

^b UNIVERSITY OF SALERNO   (Italy)

^c Dipto Clin Sperim Med Farmacol   (Italy)

Author keywords

Aorta; Hyporeactivity; Inducible nitric oxide synthase; Lipopolysaccharide; Melatonin; Poly (ADP ribose) synthetase; Rat

Indexed keywords

3 NITROTYROSINE; ACETYLCHOLINE; AUTACOID; INDUCIBLE NITRIC OXIDE SYNTHASE; LIPOPOLYSACCHARIDE; MELATONIN; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE; NITRIC OXIDE; PHENYLEPHRINE; REACTIVE OXYGEN METABOLITE; SUPEROXIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIOXIDANT ACTIVITY; ARTICLE; BLOOD VESSEL REACTIVITY; CONTROLLED STUDY; ENDOTHELIUM INJURY; ENDOTOXEMIA; ESCHERICHIA COLI; HEMORRHAGIC SHOCK; HYPOTENSION; IMMUNOHISTOCHEMISTRY; IMMUNOMODULATION; INFLAMMATION; MALE; NONHUMAN; PINEAL BODY; RAT; SEPTIC SHOCK; VASCULAR RING;

EID: 1842453132     PISSN: 07423098     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1600-079x.2003.00111.x     Document Type: Article

References (54)

1. PINSKY MR, MATUSCHAK GM. Multiple systems organ failure: failure of host defense homeostasis. Crit Care Clin 1989; 5:199-220.
2. DE WARRA I, JACCARD C, CORRADIN SB et al. Cytokines, nitrite/nitrate, soluble tumor necrosis factor receptors, and procalcitonin concentrations: comparisons in patients with septic shock, cardiogenic shock, and bacterial pneumonia. Crit Care Med 1997; 25:607-613.
3. BECKMAN J, BECKMAN TW, CHEN J et al. Apparent hydroxyl radical production by peroxynitrite: implication for endothelial injury from nitric oxide and superoxide. Proc Natl Acad Sci U S A 1990; 87:1620-1624.
4. ZINGARELLI B, DAY BJ, CRAPO JD, SALZMAN AL, SZABO C. The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol 1997; 120:259-267.
5. SZABO C, ZINGARELLI B, O'CONNOR M, SALZMAN AL. DNA strand breakage, activation of poly(ADP-ribose)synthetase, and cellular energy depletion are involved in the cytotoxicity of macrophages and smooth muscle cells exposed to peroxynitrite. Proc Natl Acad U S A 1996; 93:1753-1758.
6. SALVEMINI D, CUZZOCREA S. Oxidative stress in septic shock and disseminated intravascular coagulation. Free Radic Biol Med 2002; 33:1173-1185.
7. MACARTHUR H, WESTFALL TC, RILEY DP, MISKO PT, SALVEMINI D. Inactivation of chatecolamines by superoxide gives new insights on the pathogenesis of septic shock. PNAS 2000; 97:9753-9758.
8. HEIKKILA RE. In: Handbook of Methods for Oxygen Radicals Research. Ed. Greenwald RA, CRC, Boca Raton, FL, 1985; pp. 233-235.
9. OZDULGER A, CINEL I, KOKSEL O et al. The protective effect of n-acetylcysteine on apoptotic lung injury in cecal ligation and punture-induced sepsis mode. Shock 2003; 19:366-372.
10. THIEMERMANN C. Membrane-permeable radical scavenger (tempol) for shock, ischemia-reperfusion injury, and inflammation. Crit Care Med 2003; 31:S76-84.
11. SALVEMINI D, CUZZOCREA S. Thetapeutic potential of superoxide mimetics as therapeutic agents in critical care medicine. Crit Care Med 2003; 31:S29-38.
12. REITER RJ. Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 1998; 56:359-384.
13. MENENDEZ-PELAEZ A, REITER RJ. Distribution of melatonin in mammalian tissue: the relative importance of nuclear versus cytosolic localization. J Pineal Res 1993; 15:59-69.
14. REITER RJ, MELCHIORRI D, SEWERYNEK E et al. A review on the evidence supporting melatonin's role as an antioxidant. J Pineal Res 1995; 18:1-11.
15. STATISCA P, ULANSKI P, ROSIAK JM. Melatonin as a hydroxyl radical scavenger. J Pineal Res 1998; 25:65-66.
16. SEWERYNEK P, MELCHIORRI D, REITER RJ et al. Lipopolysaccharide-induced hepatotoxicity is inhibited by the antioxidant melatonin. Eur J Pharmacol 1995; 293:327-334.
17. MELCHIORRI D, REITER JR, ATTIA AM et al. Potent protective effect of melatonin on in vivo paraquat-induced oxidative damage in rats. Life Sci 1995; 56:83-89.
18. GILAD E, CUZZOCREA S, ZINGARELLI B et al. Melatonin is a scavenger of peroxynitrite. Life Sci 1997; 60:PL169-174.
19. GUERRERO JM, REITER RJ, ORTIZ GC et al. Melatonin prevents increase in neuronal nitric oxide and cyclic GMP production after transient brain ischemia and reperfusion in the Mongolian gerbil (Meriones unguiculatus). J Pineal Res 1997; 23:4-31.
20. CUZZOCREA S, MAZZON E, COSTANTINI G et al. Effect of n-acetylcysteine in a rat model of ischemia and reperfusion injury. Cardiovas Res 2000; 18:537-548.
21. BANNERMAN DD, GOLDBLUM SE. Mechanism of bacterial lipopolysaccharide- induced endothelial apoptosis. Am J Physiol Cell Mol Physiol 2003; 284:L899-L914.
22. 2-induced lipid peroxidation in rat brain homogenates is greatly reduced by melatonin. Neurosci Lett 1995; 195:203-205.
23. SEWERYNEK E, MELCHIORRI D, CHEN L et al. Melatonin reduces both basal and bacterial lipopolysaccharide-induced lipid peroxidation in vitro. Free Radic Biol Med 1995; 19:903-909.
24. SEWERYNEK E, ABE M, CHEN L, ORTIZ GG, REITER RJ. Oxidative changes in the liver, brain and lens of lipopolysaccharide-treated rats. Arch Med Res 1995; 26:S109-115.
25. 2+ pump in pig coronary artery smooth muscle. Am J Physiol Cell Physiol 2003; 284:C294-C301.
26. MARSHALL KA, REITER RJ, POEGGELER B et al. Evaluation of the antioxidant activity of melatonin in vitro. Free Radic Biol Med 1996; 21:307-315.
27. SZABO C. Multiple pathways of peroxynitrite cytotoxicity. Toxicol Lett 2003; 140-141:105-112.
28. GAAL JC, SMITH KR, PEARSON CK. Cellular euthanasia mediated by a nuclear enzyme: a central role for nuclear ADP-ribosilation in cellular mechanism. Trends Biochem 1987; 12:129-130.
29. HA HC, SNIDER SH. Poly (ADP-ribose) polymerase-1 is a mediator of necrotic cell death by ATP depletion. Proc Natl Acad Sci U S A 1999; 69:13978-13982.
30. MORONI F, MELI E, PERUGINELLI F et al. Poly (ADP-ribose) polymerase inhibitors attenuate necrotic but non-apoptotic neuronal death in experimental models of cerebral ischemia. Cell Death Diff 2001; 8:921-932.
31. VERES B, GALLYAS F Jr. VARBIRO G et al. Decrease of the inflammatory response and induction of the Akt/protein kinase B pathway by poly-(ADP-ribose) polymerase 1 inhibitor in endotoxin-induced septic shock. Biochem Pharmacol 2003; 65:1373-1382.
32. PANARO MA, BRANDONISIO O, ACQUAFREDDA A et al. Evidences for iNOS Expression and nitric oxide production in the human macrophages. Curr Drug Targets Immune Endocr Metabol Disord 2003; 3:210-221.
33. ZINGARELLI B, DAY BJ, CRAPO JD et al. The potential role of peroxynitrite in the vascular contractile and cellular energetic failure in endotoxic shock. Br J Pharmacol 1997; 120:259-267.
34. CRESPO E, MACÌAS M, POZO D et al. Melatonin inhibits expression of the inducible NO synthase II in liver and lung and prevents endotoxemia in lipopolysaccharide-induced multiple organ dysfunction syndrome in rats. FASEB J 1999; 13:1537-1546.
35. MOHAN N, SADEGHI K, REITER RJ, MELTZ ML. The neurohormone melatonin inhibits cytokine, mitogen and ionizing radiation induced NF-kappa B. Biochem Mol Biol Int 1995; 37:1063-1070.
36. GARCIA-MURINO S, POZO D, CALVO JR, GUERRERO JM. Correlation between nuclear melatonin receptor expression and enhanced cytokine production in human lymphocytic and monocytic cell lines. J Pineal Res 2000; 29:129-137.
37. BESNARD S, BAKOUCHE J, LEMAIGRE-DUBREUIL Y et al. Smooth muscle dysfunction in resistance arteries of the stagger mouse, a mutant of the nuclear receptor RORα. Circ Res 2002; 90:820-825.
38. BECKMAN JS, KOPPENOL WH. Nitric oxide, superoxide, and peroxynitrite: the good, the bad, and ugly. Am J Physiol 1996; 271(5 Pt 1):C1424-1437.
39. ALLEGRA M, REITER RJ, TAN DX et al. The chemistry of melatonin's interaction with reactive species. J Pineal Res 2003; 58:10-19.
40. EISERICH JP, HRISTOVA M, CROSS CE et al. Formation of nitric oxide-derived inflammatory oxidants by myeloperoxidase in neutrophils. Nature 1998; 391:393-397.
41. TAN DX, MANCHESTER LC, HARDELAND R et al. Melatonin: a hormone, a tissue factor, an autocoid, a paracoid, and an antioxidant vitamin. J Pineal Res 2003; 34:75-78.
42. PABLOS MI, AGAPITO MT, GUTIERREZ R et al. Melatonin stimulates the activity of the detoxifying enzyme glutathione peroxidase in several tissues of chicks. J Pineal Res 1995; 19:111-115.
43. CHEUNG RTF. The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res 2003; 34:153-160.
44. REITER RJ, TAN DX. Melatonin: a novel protective against oxidative injury of the ischemic/reperfusion heart. Cardiovasc Res 2003; 58:10-19.
45. GIUSTI P, LIPARTITI M, FRANCESCHINI D et al. Neuroprotection by melatonin from kinate-induced excitotoxicity in rats. FASEB J 1996; 10:891-896.
46. MAESTRONI GJ. Melatonin as a therapeutic agent in experimental endotoxic shock. J Pineal Res 1996; 20:84-89.
47. NAVA F, CALAPAI G, FACCIOLA G et al. Melatonin effects on inhibition of thirst and fever induced by lipopolysaccharide in rat. Eur J Pharmacol 1997; 331:267-274.
48. SZABO C. The pathophysiological role of peroxynitrite in shock, inflammation, and ischemia-reperfusion injury. Shock 1996; 6:79-88.
49. LISSONI P, BRIVIO F, BARNI S et al. Neuroimmunotherapy of human cancer with interleukin-2 and the neurohormone melatonin: its efficacy in preventing hypotension. Anticancer Res 1990; 10(November-December):1759-1761.
50. LISSONI P, PITTALIS S, ARDIZZOIA A et al. Prevention of cytokine-induced hypotension in cancer patients by the pineal hormone melatonin. Support Care Cancer 1996; 4(Jul):313-316.
51. ZINGARELLI B, VIRAG L, SZABO A et al. Oxidation, tyrosine nitration and cytostasis induction in the absence of inducible nitric oxide synthase. Int J Mol Med 1998; 1:787-795.
52. GRAHAM DG. Oxidative pathways for catecholamines in the genesis of neuromelanin and cytotoxic quinones. Mol Pharmacol 1978; 14:633-643.
53. HEIKKILA RE, CABBAT FS. A sensitive assay for superoxide dismutase based on the autoxidation of 6-hydroxydopamine. Anal Biochem 1976; 75:356-362.
54. ANNANE D. Replacement therapy with hydrocortisone in catecolamine- dependent septic shock. J Endotoxin Res 2001; 7:305-309.